524 related articles for article (PubMed ID: 11185554)
1. 1alpha,25-dihydroxy-16-ene-23-yne-vitamin D3 and 1alpha,25-dihydroxy-16-ene-23-yne-20-epi-vitamin D3: analogs of 1alpha,25-dihydroxyvitamin D3 that resist metabolism through the C-24 oxidation pathway are metabolized through the C-3 epimerization pathway.
Reddy GS; Rao DS; Siu-Caldera ML; Astecker N; Weiskopf A; Vouros P; Sasso GJ; Manchand PS; Uskokovic MR
Arch Biochem Biophys; 2000 Nov; 383(2):197-205. PubMed ID: 11185554
[TBL] [Abstract][Full Text] [Related]
2. Removal of C-ring from the CD-ring skeleton of 1alpha,25-dihydroxyvitamin D3 does not alter its target tissue metabolism significantly.
Reddy GS; Robinson M; Wang G; Palmore GT; Gennaro L; Vouros P; De Clercq P; Vandewalle M; Young W; Ling S; Verstuyf A; Bouillon R
Arch Biochem Biophys; 2007 Apr; 460(2):254-61. PubMed ID: 17196157
[TBL] [Abstract][Full Text] [Related]
3. Metabolism of selective 20-epi-vitamin D
Flarakos CC; Weiskopf A; Robinson M; Wang G; Vouros P; Sasso GJ; Uskokovic MR; Reddy GS
Steroids; 2017 Mar; 119():18-30. PubMed ID: 28089927
[TBL] [Abstract][Full Text] [Related]
4. Tissue specific metabolism of 1alpha,25-dihydroxy-20-epi-vitamin D3 into new metabolites with significant biological activity: studies in rat osteosarcoma cells (UMR 106 and ROS 17/2.8).
Siu-Caldera ML; Rao DS; Astecker N; Weiskopf A; Vouros P; Konno K; Fujishima T; Takayama H; Peleg S; Reddy GS
J Cell Biochem; 2001; 82(4):599-609. PubMed ID: 11500938
[TBL] [Abstract][Full Text] [Related]
5. Selective inhibition of cyclooxygenase-2 (COX-2) by 1alpha,25-dihydroxy-16-ene-23-yne-vitamin D3, a less calcemic vitamin D analog.
Aparna R; Subhashini J; Roy KR; Reddy GS; Robinson M; Uskokovic MR; Venkateswara Reddy G; Reddanna P
J Cell Biochem; 2008 Aug; 104(5):1832-42. PubMed ID: 18348265
[TBL] [Abstract][Full Text] [Related]
6. Production of 1alpha,25-dihydroxy-3-epi-vitamin D3 in two rat osteosarcoma cell lines (UMR 106 and ROS 17/2.8): existence of the C-3 epimerization pathway in ROS 17/2.8 cells in which the C-24 oxidation pathway is not expressed.
Siu-Caldera ML; Sekimoto H; Weiskopf A; Vouros P; Muralidharan KR; Okamura WH; Bishop J; Norman AW; Uskoković MR; Schuster I; Reddy GS
Bone; 1999 May; 24(5):457-63. PubMed ID: 10321905
[TBL] [Abstract][Full Text] [Related]
7. Highly active analogs of 1alpha,25-dihydroxyvitamin D(3) that resist metabolism through C-24 oxidation and C-3 epimerization pathways.
Uskokovic MR; Norman AW; Manchand PS; Studzinski GP; Campbell MJ; Koeffler HP; Takeuchi A; Siu-Caldera ML; Rao DS; Reddy GS
Steroids; 2001; 66(3-5):463-71. PubMed ID: 11179755
[TBL] [Abstract][Full Text] [Related]
8. 1Alpha,25-dihydroxy-3-epi-vitamin D3, a natural metabolite of 1alpha,25-dihydroxyvitamin D3, is a potent suppressor of parathyroid hormone secretion.
Brown AJ; Ritter C; Slatopolsky E; Muralidharan KR; Okamura WH; Reddy GS
J Cell Biochem; 1999 Apr; 73(1):106-13. PubMed ID: 10088729
[TBL] [Abstract][Full Text] [Related]
9. Isolation and identification of 1alpha-hydroxy-3-epi-vitamin D3, a potent suppressor of parathyroid hormone secretion.
Brown AJ; Ritter CS; Weiskopf AS; Vouros P; Sasso GJ; Uskokovic MR; Wang G; Reddy GS
J Cell Biochem; 2005 Oct; 96(3):569-78. PubMed ID: 16088954
[TBL] [Abstract][Full Text] [Related]
10. Growth inhibitory effects on human colon adenocarcinoma-derived Caco-2 cells and calcemic potential of 1 alpha,25-dihydroxyvitamin D3 analogs: structure-function relationships.
Bischof MG; Redlich K; Schiller C; Chirayath MV; Uskokovic M; Peterlik M; Cross HS
J Pharmacol Exp Ther; 1995 Dec; 275(3):1254-60. PubMed ID: 8531089
[TBL] [Abstract][Full Text] [Related]
11. C-25 hydroxylation of 1alpha,24(R)-dihydroxyvitamin D3 is catalyzed by 25-hydroxyvitamin D3-24-hydroxylase (CYP24A1): metabolism studies with human keratinocytes and rat recombinant CYP24A1.
Astecker N; Bobrovnikova EA; Omdahl JL; Gennaro L; Vouros P; Schuster I; Uskokovic MR; Ishizuka S; Wang G; Reddy GS
Arch Biochem Biophys; 2004 Nov; 431(2):261-70. PubMed ID: 15488475
[TBL] [Abstract][Full Text] [Related]
12. Cell specificity and properties of the C-3 epimerization of Vitamin D3 metabolites.
Kamao M; Tatematsu S; Sawada N; Sakaki T; Hatakeyama S; Kubodera N; Okano T
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):39-42. PubMed ID: 15225744
[TBL] [Abstract][Full Text] [Related]
13. Profile of ligand specificity of the vitamin D binding protein for 1 alpha,25-dihydroxyvitamin D3 and its analogs.
Bishop JE; Collins ED; Okamura WH; Norman AW
J Bone Miner Res; 1994 Aug; 9(8):1277-88. PubMed ID: 7976510
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of all possible A-ring diastereomers at the 1- and 3-positions of 1alpha,25-dihydroxy-2beta-(3-hydroxypropoxy)vitamin D3 (ED-71) using C2-symmetrical epoxide as a common starting material.
Kubodera N; Hatakeyama S
Anticancer Res; 2009 Sep; 29(9):3571-8. PubMed ID: 19667150
[TBL] [Abstract][Full Text] [Related]
15. Isolation, identification and biological activity of 24R,25-dihydroxy-3-epi-vitamin D3: a novel metabolite of 24R,25-dihydroxyvitamin D3 produced in rat osteosarcoma cells (UMR 106).
Kamao M; Tatematsu S; Reddy GS; Hatakeyama S; Sugiura M; Ohashi N; Kubodera N; Okano T
J Nutr Sci Vitaminol (Tokyo); 2001 Apr; 47(2):108-15. PubMed ID: 11508700
[TBL] [Abstract][Full Text] [Related]
16. Metabolism of 2-methyl analogs of 1alpha,25-dihydroxyvitamin D3 in rat osteosarcoma cells (UMR 106).
Sunita Rao D; Siu-Caldera ML; Sekimoto H; Gennaro L; Vouros P; Takayama H; Konno K; Fujishima T; Reddy GS
Biol Pharm Bull; 2002 Jul; 25(7):845-52. PubMed ID: 12132655
[TBL] [Abstract][Full Text] [Related]
17. Metabolism of 1alpha,25-dihydroxyvitamin D(3) in human promyelocytic leukemia (HL-60) cells: in vitro biological activities of the natural metabolites of 1alpha,25-dihydroxyvitamin D(3) produced in HL-60 cells.
Rao DS; Campbell MJ; Koeffler HP; Ishizuka S; Uskokovic MR; Spagnuolo P; Reddy GS
Steroids; 2001; 66(3-5):423-31. PubMed ID: 11179751
[TBL] [Abstract][Full Text] [Related]
18. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
19. Metabolic stability of 3-epi-1α,25-dihydroxyvitamin D3 over 1 α 25-dihydroxyvitamin D3: metabolism and molecular docking studies using rat CYP24A1.
Rhieu SY; Annalora AJ; Wang G; Flarakos CC; Gathungu RM; Vouros P; Sigüeiro R; Mouriño A; Schuster I; Palmore GT; Reddy GS
J Cell Biochem; 2013 Oct; 114(10):2293-305. PubMed ID: 23606409
[TBL] [Abstract][Full Text] [Related]
20. Differential activities of 1alpha,25-dihydroxy-16-ene-vitamin D(3) analogs and their 3-epimers on human promyelocytic leukemia (HL-60) cell differentiation and apoptosis.
Nakagawa K; Sowa Y; Kurobe M; Ozono K; Siu-Caldera ML; Reddy GS; Uskokovic MR; Okano T
Steroids; 2001; 66(3-5):327-37. PubMed ID: 11179741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
